JINGHUA PHARM's subsidiary LuHuaSenXuan leads the formulation of an industry standard approved by the National Standardization Administration

Zhitong
2025.09.16 08:53
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, JINGHUA PHARM announced that the industry standard for "1,3-Dioxolane" led by its subsidiary Shandong Luhuasenxuan New Materials Co., Ltd. (referred to as "Luhuasenxuan") has passed the review by the National Standardization Administration and has been announced by the Ministry of Industry and Information Technology. This standard will officially take effect on March 1, 2026

According to the Zhitong Finance APP, JINGHUA PHARM (002349.SZ) announced that the industry standard for "1,3-Dioxolane" led by its subsidiary Shandong Luhuasenxuan New Materials Co., Ltd. (referred to as "Luhuasenxuan") has passed the review by the National Standardization Administration and has been announced by the Ministry of Industry and Information Technology. This standard will officially take effect on March 1, 2026

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer